Bioinformatics, Gene, Gene Therapy and Production

Guide to using AAV vectors in gene therapy

Drug Discovery World

FEBRUARY 8, 2024

In 2023, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. How is the titer determined?

Gene Therapy

Gene Therapy Gene Bioinformatics Life Science

Exclusive event on using adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

JULY 5, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy

Gene Therapy Gene Bioinformatics Life Science

Learn how to use adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

JUNE 29, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy

Gene Therapy Gene Bioinformatics Life Science

A guide to using adeno-associated virus (AAV) vectors in gene therapy

Drug Discovery World

JUNE 22, 2023

Join DDW for this exclusive free event , A Comprehensive Guide to Using Adeno-Associated Virus (AAV) Vectors in Gene Therapy, which is supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy

Gene Therapy Gene Bioinformatics Life Science

Guide to using AAV vectors in gene therapy

Drug Discovery World

OCTOBER 3, 2023

Earlier this year, DDW hosted a webinar, ‘A comprehensive guide to using adeno-associated virus (AAV) vectors in gene therapy’, supported by Azenta Life Sciences. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.

Gene Therapy

Gene Therapy Gene Life Science Bioinformatics

Start-up hopes to boost production of viral vectors for ATMPs

Drug Discovery World

MAY 16, 2023

New South African company NewBiologix has launched with the aim of developing a proprietary and breakthrough platform for the advanced engineering of cell lines used to manufacture gene and cell therapies. Current gene and cell therapies primarily focus on rare diseases.

Production

Production Gene Therapy Gene Bioinformatics

Drug discovery deals highlight key growth areas

Drug Discovery World

OCTOBER 20, 2023

GenomeFrontier partners with BioCina on CAR-T therapy CDMO BioCina and GenomeFrontier Therapeutics will partner on the development of virus-free CAR-T products for cancer treatment. BioCina will provide process development and GMP manufacturing for Minicircle DNA and Plasmid DNA.

Drugs

Drugs Antibody DNA Gene Therapy

Cancer Research UK partnership aims to back 10 new startups

pharmaphorum

JULY 20, 2022

The two organisations have previously collaborated on the creation of three cancer therapeutics companies, including bacterial delivery system developer Neobe therapeutics, oncolytic virus therapy company Stratosvir, and bioinformatics specialist Enedra.

Research

Research Bioinformatics Gene Therapy Medicine

Drug discovery’s senior appointments for Q4

Drug Discovery World

NOVEMBER 30, 2023

Organ-on-a-chip company CN Bio has appointed Neil Rumbelow as Director of Product Development, and who joins CN Bio from Owlstone Medical where he was Head of Engineering. Jones has over 10 years of senior leadership experience in oncology research and was most recently Executive Product Director of Clinical Data at AstraZeneca.

Drugs

Drugs Genome Genomics Bioinformatics

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

pharmaphorum

APRIL 15, 2021

We have a pipeline of novel therapeutics and technological approaches, advancing a diverse array of candidates, including small molecules, biologics and cell and gene therapies, so a lot of the time we are working where there’s little, or no precedent.”. The impact of COVID-19 and implications for the future.

Development

Development Manufacturing Production Bioinformatics

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

NOVEMBER 9, 2023

Thomas Valerius, MD, Professor, Stem Cell Transplantation & Immunotherapy, Christian Albrechts University of Kiel, on: ‘Neutrophil-activating therapy for the treatment of cancer’. Lei Shi, PhD, Senior Vice President, R&D, Biointron Biological, on: ‘Accelerating early discovery through htp and high-speed antibody production’.

Engineer

Engineer Antibody Protein In-Vivo

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

NOVEMBER 13, 2023

Novel/alternative ML-enabled screening technologies for higher POS Following chairperson’s remarks from M Frank Erasmus, PhD, Head, Bioinformatics, Specifica, there will be four presentations and a panel discussion. Jens Frauenfeld, PhD, Founder, CEO, Salipro Biotech, on: ‘Structure-function studies of salipro-CXCRs for antibody development’.

Protein

Protein Antibody Engineer Scientist

FAIR Game: making data work harder in the race to market

Drug Discovery World

OCTOBER 17, 2022

By Dr Christof Gänzler, Product Marketing Biology at PerkinElmer Informatics. . The end game: reducing late-stage candidate failure and driving stronger innovation, productivity, and throughput. It’s a centuries-old truism: the fastest runner doesn’t always win the race. It takes more than speed to advance and maintain performance.

Marketing

Marketing Scientist Gene Expression Drugs

Clinical Research Informer

Guide to using AAV vectors in gene therapy

Exclusive event on using adeno-associated virus (AAV) vectors in gene therapy

Trending Sources

Learn how to use adeno-associated virus (AAV) vectors in gene therapy

A guide to using adeno-associated virus (AAV) vectors in gene therapy

Guide to using AAV vectors in gene therapy

Start-up hopes to boost production of viral vectors for ATMPs

Drug discovery deals highlight key growth areas

Cancer Research UK partnership aims to back 10 new startups

Drug discovery’s senior appointments for Q4

Global impact: How regulatory affairs is shaping development of cutting-edge pharma innovation

What to expect from PEGS Europe 2023: Day 2

What to expect from PEGS Europe 2023: Day 3

FAIR Game: making data work harder in the race to market

Stay Connected